Executive leads growth of Neuromonics Tinnitus Treatment.BETHLEHEM, Pa., May 8, 2012 - Neuromonics, Inc., has named Curtis Amann vice president of marketing and sales.
Neuromonics manufactures and distributes the only FDA-cleared, patented and clinically proven medical device designed for long-term significant relief of tinnitus. Clinically administered and monitored, the Neuromonics Tinnitus Treatment uses the non-invasive device, customized to each patient's individual audiological profile, to deliver a neural stimulus that targets the brain's auditory pathways.
Amann joined Neuromonics in 2007, and served as a territory sales manager and director of sales since that time. Before his work with Neuromonics, he was a territory manager for ArthroCcare ENT (Austin, Texas), working with surgical instruments for ear, nose and throat surgeons. He also worked as a sales specialist for Tyco Healthcare/Kendall (New Orleans), working with vascular therapy products.
In addition, the new vice president has held the positions of assistant director of corporate sales and athletic director of marketing at Tulane University, and account development manager with MCI Communications in New Orleans.
Amann holds Master of Business Administration and Bachelor of Arts degrees from Tulane University.
Neuromonics, Inc. (www.neuromonics.com)
Based in Bethlehem, Pa., Neuromonics, Inc., manufactures and distributes the FDA-cleared, patented and clinically proven medical device designed for long-term significant relief of tinnitus. With research and development beginning in the early 1990s, the Neuromonics Tinnitus Treatment has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. The treatment has been featured on national news media including "The Doctors" and CNN.
For more information about Neuromonics visit www.neuromonics.com or the Neuromonics Web Channel on Audiology Online.
